Sonja Schrepfer

Company: Sana Biotechnology

Job title: Senior Vice President, Hypoimmune Platform

Seminars:

Genetic Engineering of Allogeneic Donor Cells For Acceptance by the Host’s Immune System 1:30 pm

Overcoming the immune barrier in allogeneic cell transplantation – discussion of the concept of immune evasion Understanding the immune response to different iPSC-derived cell types in different transplantation sites From mice to patients – various preclinical and translational models to bridge the gap from bench to bedsideRead more

day: Conference Day Two

Roundtable Discussion: Combatting Limitations with Preclinical Models to Improve Translation of iPSC-Derived Therapies to the Clinic 2:40 pm

Acknowledging current limitations with existing animal models to identify areas for greater discovery Discussing alternative approaches to enhance quality of preclinical efficacy, safety and toxicology data Benchmarking critical qualities of preclinical models to ensure accurate reflection of disease indicationsRead more

day: Track A MID